Team:Paris Bettencourt/Human Practice/Overview
From 2012.igem.org
(Difference between revisions)
Line 38: | Line 38: | ||
#:* '''''Creating a system as robust as possible''''', that is many mutations away from failure (this is what our [https://2012.igem.org/Team:Paris_Bettencourt/Overview bench work] has been all about) (addresses issue C and F), | #:* '''''Creating a system as robust as possible''''', that is many mutations away from failure (this is what our [https://2012.igem.org/Team:Paris_Bettencourt/Overview bench work] has been all about) (addresses issue C and F), | ||
#:* '''''Creating a safety page on the biobrick registry''''' where all the safety devices that exist are listed and characterized (included evaluation of their robustness) in order for iGEM teams to pick the most appropriate device to add to their newly created genetic circuit. Ultimately, we would like '''''the integration of safety modules and risks assessments to be part of of every synthetic biology project from the very start''''' (already listed in the safety page or created de novo by the team) (addresses issue D, F), [http://partsregistry.org/Biosafety Go to safety page] | #:* '''''Creating a safety page on the biobrick registry''''' where all the safety devices that exist are listed and characterized (included evaluation of their robustness) in order for iGEM teams to pick the most appropriate device to add to their newly created genetic circuit. Ultimately, we would like '''''the integration of safety modules and risks assessments to be part of of every synthetic biology project from the very start''''' (already listed in the safety page or created de novo by the team) (addresses issue D, F), [http://partsregistry.org/Biosafety Go to safety page] | ||
- | #:*The community has to build a collection of bio-safety devices for future engineers | + | #:*The community has to '''''build a collection of bio-safety devices for future engineers''''' |
- | #:*Each synthetic biology application should assess and disclose a list of application-specific risks and hazards. | + | #:*Each synthetic biology application should '''''assess and disclose a list of application-specific risks and hazards'''''. |
- | #:*Development and adoption of a safety chasis for synthetic biology research and prototyping | + | #:*Development and adoption of a '''''safety chasis for synthetic biology research and prototyping'''''. |
You can find the full list of proposals [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Report#III_Proposals here] | You can find the full list of proposals [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Report#III_Proposals here] |
Revision as of 23:38, 26 September 2012
Human Practice
Aim To chart new venues of best practice for synthetic biology. To this end, we examined the ethical, biological and social concerns related to the release of genetically modified bacteria in the wild. Metodology
You can find the full list of conclusions here Main Proposals
You can find the full list of proposals here |